Navigation Links
CryoLife Announces First Clinical Use of BioFoam(R)
Date:9/10/2009

ding statements regarding hopes that BioFoam will reduce the time required to achieve hemostasis during liver resection surgery and reduce the number of complications following surgery, potential distribution timing and uses and applications for BioFoam and timing of enrollment in the feasibility phase of the Company's BioFoam IDE submission. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. These risks and uncertainties include that BioFoam may not prove safe or effective for its intended uses, that BioFoam may not achieve hemostasis in liver resections or reduce complications following surgery due to any number of factors that we will not be able to identify until further procedures are performed, that BioFoam may not be useful in other future surgical applications, that the Company may not start feasibility phase enrollment in quarter 4 of 2009 due to any number of factors, including unanticipated delays in obtaining FDA and U.S. Department of Defense approval, and that BioFoam development may not result in a commercial product on the time table anticipated, or at all, due to factors beyond our control, including potential lack of acceptance by the medical community. For additional risks impacting the Company's business, see the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and the Company's subsequent Form 10-Q filings. The Company does not undertake to update its forward-looking statements.

For additional information about the company, visit CryoLife's Web site: http://www.cryolife.com

    Media Contacts:

    D. Ashley Lee
    Executive Vice President, Chief Financial
    Officer and Chief Operating Officer
    Phone:  770-419-3355

    Dana H
'/>"/>
SOURCE CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
2. CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material
3. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material
4. CryoLife Reports Record First Quarter Revenues of $26.7 Million
5. CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results
6. CryoLife to Present at Sidotis 13th Annual New York Emerging Growth Institutional Forum
7. CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
8. CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results
9. CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
10. CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference
11. CryoLifes Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces that results of a large, European ... patients with hepatic metastases with the Delcath Hepatic ... an on-line abstract at the American Society of ...
(Date:5/29/2015)... RESEARCH TRIANGLE PARK, N.C. , May 29, ... announced today that Roger Jeffs , Ph.D., President and ... and update on the company,s business at the Jefferies 2015 ... . The presentation and the immediately following Q&A ... 11:00 AM Eastern Time, and can be accessed via a ...
(Date:5/28/2015)... 2015 Research and ... addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... report deals with therapeutic drug monitoring, a ... care by monitoring drug levels in the ...
(Date:5/28/2015)... , May 27, 2015 Research and ... Jain PharmaBiotech,s new report "Cell Therapy - ... This report describes and evaluates cell ... to play an important role in the practice ... the old fashioned bone marrow transplants. Role of ...
Breaking Biology Technology:Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Global Therapeutic Drug Monitoring Market 2015-2024 2Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2
... , There,s good news in the search for ... U.S. Department of Energy,s Lawrence Berkeley National Laboratory ... Berkeley, have successfully integrated ultra-thin layers of the ... create a nanoscale transistor with excellent electronic properties. ...
... Crescent Healthcare today announced a planned expansion of their ... to open an infusion pharmacy in Totowa, New Jersey, ... current patients in Massachusetts, Maryland, New York, New Jersey, ... In addition to supporting current business ...
... 2010 Reportlinker.com announces that a new market ... Global Bladder Cancer Therapeutics Industry ... report analyzes the worldwide markets for Bladder Cancer ... comprehensive analytics for US, Japan, Europe, and Rest ...
Cached Biology Technology:Ultrathin alternative to silicon for future electronics 2Ultrathin alternative to silicon for future electronics 3Crescent Healthcare Expands East Coast Presence 2Reportlinker Adds Global Bladder Cancer Therapeutics Industry 2Reportlinker Adds Global Bladder Cancer Therapeutics Industry 3Reportlinker Adds Global Bladder Cancer Therapeutics Industry 4Reportlinker Adds Global Bladder Cancer Therapeutics Industry 5Reportlinker Adds Global Bladder Cancer Therapeutics Industry 6Reportlinker Adds Global Bladder Cancer Therapeutics Industry 7Reportlinker Adds Global Bladder Cancer Therapeutics Industry 8Reportlinker Adds Global Bladder Cancer Therapeutics Industry 9Reportlinker Adds Global Bladder Cancer Therapeutics Industry 10Reportlinker Adds Global Bladder Cancer Therapeutics Industry 11Reportlinker Adds Global Bladder Cancer Therapeutics Industry 12Reportlinker Adds Global Bladder Cancer Therapeutics Industry 13
(Date:5/8/2015)... 8, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... members of the executive management team will present at the ... Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company Technology, ... ET Location: The New York Palace Hotel, New ...
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... , Non-melanoma skin cancer is the most common form of ... cases recorded each year in the USA alone. ... these cancers is continuously rising due mainly to the aging ... prosperity, permitting more visits to countries with high sun exposure, ...
... at the Stuttgart Natural History Museum were leading in the ... of South America. The spectacular fossils were named Coxoplectoptera ... a special issue on Cretaceous Insects in the scientific journal ... group led by Dr. Arnold H. Staniczek and Dr. Gnter ...
... scientists have defined the structure -- down to the atomic ... research may help direct efforts to develop medications that block ... by Professor Yizhi Jane Tao, postdoctoral researcher Jinhui Dong and ... Proceedings of the National Academy of Sciences . ...
Cached Biology News:Some cutaneous HPV types may be involved in non-melanoma skin cancer development 2Juvenile diarrhea virus analyzed 2Juvenile diarrhea virus analyzed 3
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
... A modified nucleotide structure called ... 5?-end of most naturally-occurring eukaryotic mRNAs ... Cap Analog for a portion of ... vitro transcription reaction results in the ...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
Biology Products: